DolPHIN-2: More Rapid Virologic Suppression With DTG- vs EFV-Based ART Initiated in Late Pregnancy

March 4-7, 2019; Seattle, Washington
In pregnant women with HIV infection who initiated third trimester ART, HIV-1 RNA < 50 copies/mL at delivery achieved in 74% with DTG-based therapy vs 43% with EFV-based therapy.
Format: Microsoft PowerPoint (.ppt)
File Size: 198 KB
Released: March 8, 2019

Acknowledgements

Directly provided by the Annenberg Center for Health Sciences at Eisenhower
ACHS Logo

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

This program is supported by independent educational grants from
Gilead Sciences
Janssen Therapeutics
Merck & Co., Inc.
ViiV Healthcare

Related Content

Dr. Samantha Strong shares key data and recommendations to consider when choosing a PrEP option for a cisgender woman, from Clinical Care Options (CCO)

Samantha Strong, PharmD, BCACP, AAHIVP, CDCES Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: October 6, 2022 Expired: October 5, 2023

Clinical Care Options (CCO) slideset providing expert insights for ART management in complex clinical situations, including extensive previous treatment

Joseph J. Eron, Jr., MD
Program Director
Jeffrey Kwong, DNP, MPH, FAANP, FAAN
Program Director
Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP
Program Director
Eric S. Daar, MD
Released: October 6, 2022

Clinical Care Options (CCO) downloadable slides from Drs Gregory Huhn, Colleen Kelley, and Darrell Tan on key advances in HIV prevention from the past year

Gregory Huhn, MD, MPHTM Colleen Kelley, MD, MPH Darrell H. S. Tan, MD, FRCPC, PhD Released: October 4, 2022

Clinical Care Options (CCO) downloadable slides from Drs Joseph Eron, Monica Gandhi, and Patrick Mallon on key advances in HIV treatment from the past year

Joseph J. Eron, Jr., MD Monica Gandhi, MD, MPH Patrick W. G. Mallon, MB, BCh, PhD, FRACP, FRCPI Released: October 4, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings